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Epidemiologic studies have reported conflicting results on the relationship between daytime napping and mortal-
ity risk, and there are few data on the potential association in the British population.We investigated the associations
between daytime napping and all-cause or cause-specific mortality in the European Prospective Investigation Into
Cancer-Norfolk study, a British population-based cohort study. Among the 16,374 men and women who answered
questions on napping habits between 1998 and 2000, a total of 3,251 died during the 13-year follow-up. Daytime
napping was associated with an increased risk of all-cause mortality (for napping less than 1 hour per day on av-
erage, hazard ratio = 1.14, 95% confidence interval: 1.02, 1.27; for napping 1 hour or longer per day on average,
hazard ratio = 1.32, 95% confidence interval: 1.04, 1.68), independent of age, sex, social class, educational level,
marital status, employment status, body mass index, physical activity level, smoking status, alcohol intake, depres-
sion, self-reported general health, use of hypnotic drugs or other medications, time spent in bed at night, and pres-
ence of preexisting health conditions. This association was more pronounced for death from respiratory diseases
(for napping less than 1 hour, hazard ratio = 1.40, 95% confidence interval: 0.95, 2.05; for napping 1 hour or more,
hazard ratio = 2.56, 95% confidence interval: 1.34, 4.86) and in individuals 65 years of age or younger. Excessive
daytime napping might be a useful marker of underlying health risk, particularly of respiratory problems, especially
among those 65 years of age or younger. Further research is required to clarify the nature of the observed
association.
aging; mortality; napping; respiratory; siesta; sleep; survival analysis
Abbreviations: BMI, bodymass index; CI, confidence interval; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular
diseases; EPIC, European Prospective Investigation Into Cancer; HR, hazard ratio; ICD, International Classification of Diseases;
MDD, major depressive disorder; OSA, obstructive sleep apnea.
In recent years, there has been growing evidence of a rela-
tionship between habitual sleep and the risk of mortality from
all-causes and cardiovascular diseases (CVDs) (1–3). Most
of these studies focused on nighttime sleep duration (4, 5);
the implications of daytime napping are poorly understood.
A long-established practice in Mediterranean areas, daytime
napping, namely siesta, is often linked with good health
through a postulated “stress relief”mechanism (6). However,
daytime sleepiness, often characterized by daytime napping,
has been suggested as an early sign or risk indicator of a range
of health problems (7–9). To date, the association between
daytime napping and mortality risk is uncertain.
Most previous studies have come from Mediterranean
countries (10–13), in which the incidence of and rate of
death from CVD tend to be low (6). Several prospective co-
hort studies from Israel showed that an increased mortality
rate was associated with siesta among older people (10,
11), whereas 1 study from Greece suggested that the siesta
is protective against heart-related deaths, especially in work-
ing men (12). In addition, conflicting United States–based
1115 Am J Epidemiol. 2014;179(9):1115–1124
American Journal of Epidemiology
© The Author 2014. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/3.0/), which permits unrestricted reuse, distribution, and reproduction in any medium,
provided the original work is properly cited




research has found an increased risk of death associated with
daytime napping in both men only (14) and women only (15).
In both studies, only naps of long durations were found to be
significant. A Japanese study suggested that daytime napping
was associated with increased risks of all-cause and CVD
mortality, but this association was largely explained by co-
morbid conditions (16). Meanwhile, there is limited evidence
from the British population. Although daytime napping has
not been a tradition among British adults, the prevalence of
napping is likely to increasewith the rapidly aging population
(17, 18), and it is therefore important to understand the health
associations of daytime napping among the British.
Epidemiologic evidence of` the association between day-
time napping and mortality is inconsistent and dependent on
cultural, environmental, and demographic factors (19). It re-
mains unclear whether napping is beneficial or a risk factor
for or marker of ill health. We therefore examined the associa-
tion between daytime napping and all-cause and cause-specific
mortality in a middle- to older-aged British population.
METHODS
Participants and measures
Data were drawn from the European Prospective Investiga-
tion Into Cancer (EPIC)-Norfolk prospective cohort study.
The design and study methods of EPIC-Norfolk have been
described previously (20, 21). Briefly, 25,639 men and
women aged 40–79 years were recruited using general prac-
tice age-sex registers from Norfolk, United Kingdom, and at-
tended a baseline health check during 1993–1997. These
participants were then followed up for 2 further health checks
from 1996 to 2000 and from 2006 to 2011. In between these
health examinations, participants were sent questionnaires
for completion and return by post. The Norwich District Eth-
ics Committee approved the study, and all participants gave
signed informed consent.
During 1998–2000, a total of 16,374 participants com-
pleted the following question in the health questionnaire:
“Do you normally take a nap during the day?” If they an-
swered in the affirmative, they were asked to categorize the
duration of their nap (<1 hour or ≥1 hour). Napping habits
were thereby summarized as: no napping, napping less than
1 hour, and napping 1 hour or more per day.
Covariates measured closer in time to the measurement of
napping were chosen and included those measured at base-
line or at the time of the second health check (1998–2000).
Covariates measured at baseline were social class (profes-
sionals, managerial and technical occupations, skilled work-
ers subdivided into nonmanual and manual, partly skilled
workers, or unskilled manual workers), educational level
(highest qualification attained: no qualifications, educated
to age 16 years, educated to age 18 years, or educated to de-
gree level), and physical activity level (inactive, moderately
inactive, moderately active, or active) (22). Body mass index
(BMI; weight in kilograms divided by height in meters
squared) was measured at the baseline health check. Other
covariates were reported in questionnaires during the time
of the second health check: age, marital status (single, mar-
ried, widowed, separated, or divorced), employment status
(working or not working), smoking status (current, former,
or nonsmokers), alcohol intake (units of alcohol drunk
per week), self-reported general health (excellent, good,
moderate, or poor), use of hypnotic drugs (yes or no), antide-
pressant use (yes or no), use of drugs to treat chronic obstruc-
tive pulmonary disease (COPD) (yes or no), major depressive
disorder (MDD) in the previous year (yes or no) (23), and
time spent in bed at night (in hours, derived from the differ-
ences between reported rise times and bedtimes). Hypnotic
drug use was defined according to the British National For-
mulary (section 4.1) (24) and included benzodiazepines,
zaleplon, zolpidem, and zopiclone, chloral and its deriva-
tives, clomethiazole, and antihistamines. Preexisting health
conditions included self-reported stroke, myocardial infarc-
tion, diabetes, cancer, asthma, bronchitis, and emphysema,
as well as a proxy measure of obstructive sleep apnea
(OSA), with persons who were in the highest BMI quartile
and who reported taking antihypertension drugs being de-
fined as likely to have underlying OSA.
Participants were flagged for death certification at the
United Kingdom Office of National Statistics so that we
were notified of their deaths, with vital status established
for the whole cohort. The current analysis presents deaths
that occurred during followed up from January 2000 and
until December 2012. Deaths were coded initially according
to the International Classification of Diseases (ICD), Ninth
Revision, and later the Tenth Revision. The underlying
cause of death was categorized as due to CVD (ICD-9
codes 401–448 or ICD-10 codes I10–I79), cancer (ICD-9
codes 140–208 or ICD-10 codes C00–C97), or respiratory
diseases (ICD–9 codes 460–496 or ICD-10 codes J00–J99).
Statistical analysis
The present study included 16,374 participants (7,161 men
and 9,213 women) who provided information on their day-
time napping habits. The characteristics of the participants
were first compared by category of daytime napping. The
comparisons of normally distributed variables and skewed
continuous variables were based on analysis of variance
and Kruskal-Wallis test, respectively. Categorical variables
were compared using Pearson’s χ2 test.
The associations between daytime napping and all-cause
or disease-specific mortality were examined using Cox pro-
portional hazards regression models that were adjusted for
covariates. The endpoints were grouped into death from all
causes, CVD, cancer, respiratory diseases, and all other
causes. We firstly examined the proportional hazard assump-
tion using both a Kaplan-Meier plot and Schoenfeld’s test,
and no sign of violation was found for any endpoint. All co-
variates were chosen a priori based on the literature and their
relevance to napping and health. Models were constructed
with progressive adjustment of the covariates to show the as-
sociations explained by the covariates: 1) Model A was ad-
justed for age and sex; 2) model B was further adjusted for
social class, educational level, marital status, employment
status, BMI, physical activity level, smoking status, and alco-
hol intake; 3) model Cwas adjusted for the variables in model
B andMDD, self-reported general health, time spent in bed at
night, hypnotic drug use, antidepressant use, and COPD drug
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use; and 4) model D was further adjusted for the variables in
all models and preexisting health conditions. Each multivar-
iable model was built on persons for whom we had complete
measurements of all covariates.
Finally, we performed stratified analysis with adjustment
for all the covariates according to follow-up length and pre-
existing health conditions and according to potential effect
modifiers: age (≤65 vs. >65 years old), sex, smoking status
(ever vs. never smoker), employment status, BMI (dichoto-
mized using the median), MDD, time spent in bed at night
(dichotomized using the median), and nighttime sleep dura-
tion (reported in hours at the time of the third health check).
Hazard ratios (with 95% confidence intervals) were calcu-
lated using no napping as the reference group (with adjust-
ment for sex through inclusion of sex-specific baseline
hazards). The overall associations between the 2 categories
of napping and mortality were tested using the likelihood
ratio test. All statistical tests were 2-sided, and a P value
<0.05 was considered statistically significant. Analyses were
implemented in Stata, version 12.0 (StataCorp LP, College
Station, Texas).
RESULTS
During 1998–2000, napping during the day was reported
by 2,653 of 7,161 men (37.0%) and 2,228 of 9,213 women
(24.2%). Tables 1 and 2 show participants’ baseline charac-
teristics by napping habits. Among the persons who took
naps, only 10% napped for more than 1 hour per day.
Those who took naps were more likely to be men and were
on average 6 years older than those who did not nap. Persons
who took naps were more likely to be smokers, not working,
and less active and to have a lower educational level, higher
BMI, and poor self-reported general health. The above asso-
ciations were all stronger for those who napped for longer
time periods.
A total of 3,251 deaths (1,034 from CVD, 1,213 from can-
cer, 286 from respiratory diseases, and 718 from all other
causes) were observed during the 13-year follow-up. There
were 1,795 deaths in men and 1,456 in women. Table 3
shows the adjusted hazard ratios associated with napping.
After adjustment for age and sex, daytime napping was asso-
ciated with a 22% increase in the risk of all-cause mortality in
persons who napped less than 1 hour (hazard ratio (HR) =
1.22, 95% confidence interval (CI): 1.13, 1.31) and a 54%
increase for persons who napped 1 hour or longer (HR =
1.54, 95% CI: 1.31, 1.81). The hazard ratios were attenuated
to 1.14 (95% CI: 1.03, 1.27) for napping less than 1 hour and
1.34 (95% CI: 1.07, 1.68) for napping 1 hour or longer after
further adjustment for social class, educational level, marital
status, employment status, BMI, physical activity level,
smoking status, alcohol intake, MDD, self-reported general
health, hypnotic drug use, antidepressant and COPD drug
use, and time spent in bed at night. This association was little
changed after additional adjustment for preexisting health
conditions, with a 14% and 32% increase in all-cause mortal-
ity risk among those who napped for less than 1 hour or 1
hour or more per day, respectively. This association was
more pronounced for death from respiratory diseases (for
napping <1 hour, HR = 1.40, 95%CI: 0.95, 2.05; for napping
≥1 hour, HR = 2.56, 95% CI: 1.34, 4.86). No statistically sig-
nificant associations were observed for death from other
causes after full adjustments.Table 4 shows results from strat-
ified analysis for all-cause mortality. The association was
stronger in those who were younger (for napping <1 hour,
HR = 1.42, 95% CI: 1.13, 1.79; for napping ≥1 hour, HR =
1.95, 95% CI: 1.16, 3.28; P for interaction = 0.04 for persons
42–65 years of age compared with those 65–82 years of age)
and in those who had a lower BMI (for napping <1 hour,
HR = 1.32, 95% CI: 1.12, 1.56; for napping ≥1 hour, HR =
1.72, 95% CI: 1.21, 2.45; P for interaction = 0.02 for those
with a BMI of 15.2–25.7 compared with those with a BMI
of higher than 25.7). In addition, there was a suggestion
that this association was stronger in persons who reported ex-
periencingMDD in the past 12 months (for napping≥1 hour,
HR = 2.90, 95% CI: 1.12, 7.50; P for interaction = 0.13) and
in those who were working (for napping ≥1 hour, HR = 2.46,
95% CI: 1.16, 5.20; P for interaction = 0.33). No statistically
significant differences were observed by sex, cigarette smok-
ing history, time spent in bed at night, nighttime sleep duration,
or preexisting health conditions (among those who reported
no preexisting CVD, cancer, asthma, bronchitis, or underly-
ing sleep apnea at baseline and who napped for ≥1 hour,
HR = 1.41, 95%CI: 1.03, 1.93). Furthermore, there was no ev-
idence that the association attenuated with increasing length of
follow-up (in these data, the association was stronger after
6.5 years of follow-up; P for interaction = 0.07).
For respiratory deaths, the associations in current and for-
mer smokers (for napping≥1 hour, HR = 2.32, 95%CI: 1.10,
4.90) were similar to those in never smokers (for napping ≥1
hour, HR = 3.59, 95% CI: 0.95, 13.58; P for interaction =
0.49). In addition, no statistically significant differences
were observed according to age, sex, employment status,
smoking status, COPD drug use, forced expiratory volume
in 1 second, or preexisting asthma, bronchitis, or emphysema.
DISCUSSION
In the present large sample of middle- to older-aged British
adults, daytime napping of 1 hour per day or more was asso-
ciated with a 32% increase in the risk all-cause mortality dur-
ing the 13-year follow-up. This association was independent
of age, sex, social class, educational level, marital status, em-
ployment status, BMI, physical activity level, smoking status,
alcohol intake, MDD, self-reported general health, time spent
in bed at night, hypnotic drug use, antidepressant use, COPD
drug use, and preexisting health conditions and was similar
among men and women. The associations were more pro-
nounced for deaths from respiratory illness and for partici-
pants who were 65 years of age or younger. Furthermore,
the association between napping and all-cause mortality re-
mained among those without preexisting health conditions
and did not attenuate with increasing length of follow-up.
To our knowledge, this is the first study to present in detail
the association between daytime napping and cause-specific
mortality in a British population. Strengths of our study in-
clude the long follow-up and range of measures for which
we were able to adjust. Our study has several limitations.
First, 16,374 of the 25,639 participants at baseline completed
the subsequent mailed questionnaire that contained the
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Table 1. Baseline Characteristics by Categories of Napping Behaviors in 7,161 Men, European Prospective
Investigation Into Cancer-Norfolk, United Kingdom, 1998–2000
Characteristic Total No.
Time Spent Napping
None <1 hour ≥1 hour
No. % No. % No. %
All mena 7,161 4,508b 63.0 2,379 33.2 274 3.8
Age, years
≤65 4,125 3,072b 68.2 942 39.7 111 40.5
>65 3,027 1,431 31.8 1,433 60.3 163 59.5
Social class
Nonmanual worker 4,319 2,741 61.6 1,425 60.9 153 56.7
Manual worker 2,738 1,708 38.4 913 39.1 117 43.3
Education category
Lower 2,650 1,531b 34.0 989 41.6 130 47.4
Higher 4,509 2,976 66.0 1,389 58.4 144 52.6
Marital status
Single 303 193 4.3 97 4.1 13 4.7
Married 6,244 3,936 87.6 2,075 87.6 233 85.0
Otherc 588 362 8.1 198 8.4 28 10.2
Smoking status
Current smoker 608 362b 8.1 203 8.6 43 15.8
Former smoker 3,980 2,378 53.2 1,445 61.2 157 57.5
Never smoker 2,517 1,730 38.7 714 30.2 73 26.7
Category of alcohol intake
Lower 3,287 2,063 50.8 1,107 52.3 117 51.1
Higher 3,120 1,998 49.2 1,010 47.7 112 48.9
Category of body mass indexd
Lower (<25.7) 3,201 2,142b 52.8 966 45.9 93 39.9
Higher (≥25.7) 3,189 1,911 47.2 1,138 54.1 140 60.1
Physical activity level
Inactive/moderately inactive 3,834 2,295b 50.9 1,354 56.9 185 67.5
Moderately active/active 3,327 2,213 49.0 1,025 43.1 89 32.5
Major depressive disorder
No 5,976 4,448b 98.7 2,341 98.4 266 97.1
Yes 231 60 1.3 38 1.6 8 2.9
Self-reported general health
Excellent 1,150 805b 18.0 323 13.6 22 8.1
Good 4,732 3,009 67.3 1,579 66.6 144 53.1
Poor to moderate 1,233 660 14.8 468 19.8 105 38.7
Hypnotic drug use
No 7,055 4,448 98.7 2,341 98.4 266 97.1
Yes 106 60 1.3 38 1.6 8 2.9
Time in bed per night, hours
≤8.5 3,611 2,333e 60.4 1,167 57.5 111 52.6
>8.5 2,493 1,532 39.6 861 42.5 100 47.4
Preexisting health conditionsf
No 4,505 3,104b 73.1 1,285 59.7 116 47.0
Yes 2,142 1,144 26.9 867 40.3 131 53.0
a Comparison was made between men and women.
b P < 0.001.
c Widowed, separated, or divorced.
d Weight (kg)/height (m)2.
e P < 0.05.
f Stroke, myocardial infarction, cancer, asthma, bronchitis, and underlying sleep apnea.
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Table 2. Baseline Characteristics by Categories of Napping Behaviors in 9,213 Women, European Prospective
Investigation Into Cancer-Norfolk, United Kingdom, 1998–2000
Characteristic Total No.
Time Spent Napping
None <1 hour ≥1 hour
No. % No. % No. %
All womena 9,213 6,985 75.8 2,033 22.1 195 2.1
Age, years
≤65 5,820 4,888b 70.1 840 41.4 92 47.2
>65 3,378 2,084 29.9 1,191 58.6 103 52.8
Social class
Nonmanual worker 5,755 4,404 64.3 1,230 62.2 121 64.4
Manual worker 3,264 2,450 35.7 747 37.8 67 35.6
Education category
Lower 4,687 3,427b 49.1 1,146 56.4 114 58.5
Higher 4,521 3,553 50.9 887 43.6 81 41.5
Marital status
Single 387 280b 4.0 95 4.7 12 6.2
Married 6,750 5,236 75.4 1,389 68.5 125 64.4
Otherc 2,030 1,430 20.6 543 26.8 57 29.4
Smoking status
Current smoker 769 596b 8.6 142 7.1 31 16.0
Former smoker 2,997 2,205 31.9 727 36.1 65 33.5
Never smoker 5,352 4,110 59.5 1,144 56.8 98 50.5
Category of alcohol intake
Lower 4,601 3,484d 59.9 1,027 63.0 90 66.2
Higher 2,984 2,336 40.1 602 37.0 46 33.8
Category of body mass indexe
Lower (<25.7) 4,096 3,250b 52.0 766 43.6 80 48.5
Higher (≥25.7) 4,071 2,995 48.0 991 56.4 85 51.5
Physical activity level
Inactive/moderately inactive 5,551 4,092b 58.6 1,324 65.1 135 69.3
Moderately active/active 3,662 2,893 41.4 709 30.9 60 30.8
Major depressive disorder
No 7,458 5,656 93.6 1,650 94.3 153 90.5
Yes 501 385 6.4 100 5.7 16 9.5
Self-reported general health
Excellent 1,419 1,174b 16.9 225 11.1 20 10.4
Good 5,998 4,600 66.3 1,304 64.6 94 49.0
Poor to moderate 1,853 1,166 16.8 490 24.3 78 40.6
Hypnotic drug use
No 9,042 6,871d 98.4 1,983 97.5 188 96.4
Yes 171 114 1.6 50 2.5 7 3.6
Time in bed per night, hours
≤8.5 3,550 2,725d 45.2 774 45.7 51 33.6
>8.5 4,321 3,299 54.8 921 54.3 101 66.4
Preexisting health conditionsf
No 5,307 4,192b 66.9 1,015 59.4 100 63.3
Yes 2,827 2,076 33.1 693 40.6 58 36.7
a Comparison was made between men and women.
b P < 0.001.
c Widowed, separated, or divorced.
d P < 0.05.
e Weight (kg)/height (m)2.
f Stroke, myocardial infarction, cancer, asthma, bronchitis, and underlying sleep apnea.
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napping question. Compared with the rest of the participants,
these 16,374 people were more likely to be women and to
have a higher social class and educational level. Therefore,
our results may not be generalizable to populations with
lower socioeconomic status. Second, the information on nap-
ping was obtained from self-report. Previous studies (25, 26)
have shown a tendency for older people to underreport nap-
ping behaviors, and this may lead to underestimation of the
association. It was suggested that naps of less than 30minutes
(usually known as power naps) can be largely beneficial, es-
pecially among shift workers (27–29), whereas naps longer
than 30 minutes can cause sleep inertia and are usually not
recommended (30). Napping duration was categorized into
less than 1 hour and 1 hour or more in our questionnaire,
and we were therefore unable to differentiate the effects of
power naps from those of excessive napping. Although this
might have diluted the overall association, we conclude
from the current study that there is an increased health risk
associated with excessive daytime napping.
Voluntary naps and naps as a result of underlying pathol-
ogy have different implications for health, and identification
of the reasons for the naps is crucial. Although a range of
preexisting health conditions and medication use was consid-
ered in this study, we cannot rule out that our results may be
partly explained by the effects of other undiagnosed health
problems or medications not included in this study that
might cause daytime fatigue or sleepiness. Daytime napping
might be a consequence of nighttime sleep disturbance,
which has been associated with an increased risk of death
(31). Although the detailed purpose of napping was not re-
corded in the present study, the association between daytime
napping and mortality risk did not change by nighttime sleep
durations and was independent of time spent in bed at night,
which has been suggested to be a good indicator of nighttime
Table 3. Associations Between Daytime Napping and All-Cause and Cause-Specific Mortality in 16,374Men andWomen, European Prospective
Investigation Into Cancer-Norfolk, United Kingdom, 2000–2012
Time Spent Napping by
Cause and No. of Deaths Total No.
Model Aa Model Bb Model Cc Model Dd
HR 95% CI HR 95% CI HR 95% CI HR 95% CI
No napping 11,493 1.00 Referent 1.00 Referent 1.00 Referent 1.00 Referent
All-cause mortality (n = 3,251)
<1 hour 4,412 1.22e 1.13, 1.31 1.25e 1.15, 1.37 1.14f 1.03, 1.27 1.14g 1.02, 1.27
≥1 hour 469 1.54e 1.31, 1.81 1.56e 1.30, 1.88 1.34g 1.07, 1.68 1.32g 1.04, 1.68
Overall P <0.001 <0.001 <0.01 0.01
Cardiovascular disease (n = 1,034)
<1 hour 4,412 1.24f 1.09, 1.41 1.22g 1.05, 1.43 1.05 0.88, 1.26 1.00 0.81, 1.22
≥1 hour 469 1.70e 1.30, 2.21 1.59f 1.16, 2.19 1.03 0.67, 1.57 0.92 0.57, 1.48
Overall P <0.001 0.003 0.86 0.94
Cancer (n = 1,213)
<1 hour 4,412 1.17g 1.04, 1.33 1.17g 1.01, 1.34 1.15 0.97, 1.35 1.18 1.00, 1.41
≥1 hour 469 1.10 0.81, 1.50 1.15 0.81, 1.63 1.27 0.86, 1.88 1.27 0.84, 1.92
Overall P 0.04 0.09 0.18 0.12
Respiratory disease (n = 286)
<1 hour 4,412 1.36g 1.06, 1.74 1.65e 1.23, 2.23 1.45g 1.01, 2.07 1.40 0.95, 2.05
≥1 hour 469 2.3e 1.48, 3.65 2.81e 1.66, 4.75 2.51f 1.37, 4.60 2.56f 1.34, 4.86
Overall P 0.001 <0.001 <0.01 0.02
All other causes (n = 718)
<1 hour 4,412 1.22g 1.04, 1.43 1.31f 1.09, 1.58 1.18 0.95, 1.45 1.18 0.94, 1.47
≥1 hour 469 1.68f 1.21, 2.33 1.75f 1.18, 2.59 1.46 0.92, 2.32 1.56 0.96, 2.53
Overall P <0.01 <0.01 0.15 0.13
Abbreviations: CI, confidence interval; HR, hazard ratio.
a Adjusted for age and sex.
b Adjusted for the variables in model A and social class, educational level, marital status, employment status, body mass index (weight (kg)/
height (m)2), physical activity level, smoking status, and alcohol intake.
c Adjusted for the variables in model B and depression, self-reported general health, hypnotic drug use, antidepressant use, chronic obstructive
pulmonary disease drug use, and time spent in bed at night.
d Adjusted for the variables in model C and self-reported preexisting diseases and underlying sleep apnea.
e P < 0.001.
f P < 0.01.
g P < 0.05.
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Table 4. Multivariablea Associations Between Daytime Napping and All-Cause Mortality by Subgroups, European
Prospective Investigation Into Cancer-Norfolk, United Kingdom, 2000–2012
Variable No. of Deaths
Time Spent Nappingb
<1 hour ≥1 hour
HR 95% CI HR 95% CI
Length of follow-up, years
<6.5 1,189 0.89 0.73, 1.08 1.06 0.69, 1.63
≥6.5 2,062 1.10 0.97, 1.26 1.41c 1.05, 1.89
P for interaction 0.07
Age, years
≤65 783 1.42d 1.13, 1.79 1.95c 1.16, 3.28
>65 2,464 1.05 0.93, 1.19 1.19 0.90, 1.56
P for interaction 0.04
Sex
Men 1,795 1.1 0.96, 1.26 1.3 0.98, 1.71
Women 1,456 1.23c 1.02, 1.47 1.19 0.72, 1.98
P for interaction 0.70
Employment status
Working 422 1.23 0.90, 1.67 2.46c 1.16, 5.20
Not working 2,679 1.13c 1.00, 1.27 1.23 0.96, 1.59
P for interaction 0.32
Preexisting health conditionse
Yes 1,431 1.22c 1.03, 1.45 1.23 0.85, 1.77
No 1,820 1.08 0.94, 1.24 1.44c 1.04, 1.99
P for interaction 0.93
Smoking status
Current or former smoker 2,042 1.19c 1.04, 1.36 1.22 0.91, 1.63
Never smoked 1,163 1.06 0.88, 1.28 1.54 0.99, 2.37
P for interaction 0.90
Category of body mass indexf
Lower (<25.7) 1,393 1.32g 1.12, 1.56 1.72d 1.21, 2.45
Higher (≥25.7) 1,848 1.04 0.90, 1.20 1.08 0.77, 1.50
P for interaction 0.02
Major depressive disorder
Yes 136 1.52 0.79, 2.96 2.90c 1.12, 7.50
No 2,702 1.13c 1.02, 1.27 1.25 0.97, 1.62
P for interaction 0.13
Time spent in bed at night, hours
≤8.5 1,234 1.08 0.93, 1.26 1.54c 1.10, 2.16
>8.5 1,427 1.20c 1.03, 1.40 1.13 0.80, 1.61
P for interaction 0.78
Nighttime sleep duration, hoursh
<6 305 1.10 0.76, 1.60 1.64 0.69, 3.94
6–7 234 0.88 0.58, 1.32 2.02 0.78, 5.23
>7 362 1.13 0.84, 1.52 0.82 0.39, 1.74
P for interaction 0.31
Abbreviations: CI, confidence interval; HR, hazard ratio.
a Adjusted for age, sex, social class, educational level, marital status, employment status, body mass index, physical activity level,
smoking status, alcohol intake,major depressive disorder, self-reported general health, hypnotic drug use, antidepressant use, chronic
obstructive pulmonary disease drug use, time spent in bed at night, and preexisting health conditions.
b The reference group was persons who did not nap.
c P < 0.05.
d P < 0.01.
e Stroke, myocardial infarction, cancer, asthma, bronchitis, emphysema, and underlying sleep apnea.
f Weight (kg)/height (m)2.
g P < 0.001.
h Measured in the third health check in 10,520 people; the others were all measured in the second health check.
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sleep patterns in the EPIC-Norfolk population (32). In addi-
tion, a surrogate measure of OSAwas included in regression
models to help address the problem. This measure combines
BMI and hypertension, 2 strong correlates of OSA (33–35).
The surrogate measure may partly reflect the probability of
having OSA; therefore, further studies with more precise
measures of OSA and nighttime sleep quality are required
to confirm whether the association stands independent of
other sleep parameters.
Our findings are consistent with most previous studies that
have reported an association between self-reported daytime
napping and increased all-cause mortality (10, 11, 14–16,
36, 37). These studies covered populations from the Mediter-
ranean, Japan, and the United States and included primarily
older populations. The largest published report to date came
from the Japan Collaborative Cohort Study, in which a total
of 9,643 deaths were recorded and daytime napping was
found to be associated with increased mortality from specific
causes, particularly CVD (16). Indeed, most previous studies
have related daytime napping to increased CVD mortality
risk (10, 15, 16, 37). In our study, the association between
napping and CVD mortality risk was largely explained by
MDD in the previous year. MDD is commonly associated
with sleep disturbance, which might lead to excessive daytime
napping. Previous evidence based upon our cohort (23) has
shown major depression to be associated with an increased
risk of ischemic heart disease mortality, though understanding
of this association remains elusive. It is possible that the asso-
ciation between napping and CVD mortality is mostly ex-
plained by depression or MDD reported within a certain
time frame. Future studies would need to carefully examine
the role of depression in the napping-mortality association.
At the same time, several earlier studies (6, 12) from Med-
iterranean populations have suggested different findings. The
Greek EPIC cohort study, which is methodologically compa-
rable to our study, found napping to be protective against cor-
onary mortality (12). Notably, the Greek cohort included
people who were 20–86 years of age at baseline, whereas
our participants were exclusively middle- to older-aged
adults. Moreover, the association was particularly strong
among working men in their study, which might be explained
by the possible stress-releasing effect of afternoon naps (12).
This effect could have been masked in our aging population,
who are mostly retired and might take naps for other purposes,
such as compensating for declining physical functions. Inter-
estingly, in our study, the positive association between napping
and mortality was seen to be stronger among persons 65 years
of age or younger than among those older than 65 years of age
(65 years is the age by which most people have retired from
work in the United Kingdom). It is often believed that napping
is protective for younger populations and problematic for older
ones (12, 19, 37). Notably, the average age of our participants
at baseline was 62 years, so the younger persons in the present
study were not comparable to those mentioned in earlier stud-
ies (12, 38). Although it is unknown why the association was
stronger among those 65 years of age or younger, our finding
raises the possibility that napping might be more indicative of
mortality risk in this population, and this needs to be confirmed
by further studies. Unlike in previous studies (14, 36), no ev-
ident sex difference was observed in this study.
In the present study, we found large effect sizes for the as-
sociation between napping and death from respiratory disease
even though there were much fewer respiratory deaths than
CVD and cancer deaths. The association was independent
of smoking status, preexisting respiratory diseases, and
COPD drug use. This is surprising given the lack of evidence
of the associations between napping and respiratory health.
Although none of the previous studies highlighted the asso-
ciation between napping and respiratory mortality, most of
them did suggest the association with non-CVD/non-cancer
mortality (10, 15, 16), and these categories were largely made
up of respiratory mortality in our study. The reason why day-
time napping may increase respiratory mortality is not
known, but it is worth noting the interrelationship between
the cardiovascular and respiratory systems (39). Although
we failed to find an association between napping and CVD
mortality, the napping-respiratory association might not be
separate from the cardiovascular consequences of sleep prob-
lems (e.g., OSA). It seems reasonable to suggest that persons
with respiratory problems (especially hypoxic conditions)
were more likely to nap and were also more likely to die of
respiratory disease because of their underlying problems.
The incidence of OSA was not recorded directly in this
study, and a proxy measure was used to account for the ef-
fects. Given the close link between OSA and mortality (40,
41), daytime napping might well be a good surrogate measure
of OSA, which is potentially important for early detection of
OSA in the general population.
Although in this study the association between napping
and all-cause mortality remained after excluding participants
with known preexisting health conditions at baseline, it re-
mains possible that daytime napping is simply a marker of
undiagnosed health problems and of reverse causation, with
those individuals who have undiagnosed ill health napping
more. In this case, we would expect attenuation in the asso-
ciation whereby it is stronger in the immediate period of
follow-up and lessens thereafter. However, the association
seemed to be even stronger among those with a follow-up
length of 6.5 years or more. Interestingly, the association
was stronger among persons with a lower BMI. Although
the exact reason for this observation is unclear, it is worth not-
ing the “obesity paradox,” which might have been brought
about by existing physiological or pathological changes
(42, 43). It is possible that persons with lower BMI could
have been suffering from underlying illnesses that led to
weight loss and that this added to the health risk conveyed
by daytime napping.
In the United Kingdom, daytime napping is not part of the
cultural norm, and in the absence of obvious disruptions in
nighttime sleep patterns, it remains plausible that napping
might be an early sign of system disregulation and a marker
of future health problems. Alternatively, there may be a bio-
logical mechanism through which napping is associated with
mortality, for example, through inflammatory pathways, espe-
cially increased chronic low-grade inflammation. Increased
levels of inflammation have been suggested for persons with
reduced nighttime sleep durations (44), but we are unaware
of any evidence to show an association between daytime nap-
ping and inflammation. Our findings need confirmation from
further population studies that include examination of the
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relationship between napping and physiological biomarkers.
This further work could help evaluate whether there is a causal
link between napping and mortality risk or whether napping is
a marker of system disregulation or of undiagnosed respiratory
problems that lead to an increased risk of future ill health.
In summary, independent associations were found be-
tween daytime napping and an increased risk of mortality
from all causes and respiratory diseases in a large population-
based middle- to older-aged British cohort. The association
remained after exclusion of persons who died within the
first 6.5 years of follow-up and was more pronounced for
people 65 years of age or younger. The exact mechanisms
of these associations remain unknown. Further studies are
needed before any recommendations can be made. Excessive
daytime napping might be a useful marker of underlying
health risks, particularly respiratory problems, especially
among those 65 years of age or younger.
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